IL-22 IgG2-Fc (F-652)

IL-22 IgG2-Fc · EVIVE Biotechnology

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IL-22 IgG2-Fc (F-652), covering 2021-07-22 to 2021-07-22. Get the full timeline:

Most recent: Clinical Trial Update: Study of IL-22 IgG2-Fc (F-652) for Subjects With Grade II-IV Lower GI aGVHD [Phase 1, Phase 2]